UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000029638 |
|---|---|
| Receipt number | R000033857 |
| Scientific Title | Study about the prognosis factor of rhythm control treatment in patients with supraventricular tachycardia |
| Date of disclosure of the study information | 2017/10/20 |
| Last modified on | 2021/10/26 01:28:10 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Study about the prognosis factor of rhythm control treatment in patients with supraventricular tachycardia
Acronym
Study about the prognosis factor of rhythm control treatment in patients with supraventricular tachycardia
Scientific Title
Study about the prognosis factor of rhythm control treatment in patients with supraventricular tachycardia
Scientific Title:Acronym
Study about the prognosis factor of rhythm control treatment in patients with supraventricular tachycardia
Region
| Japan |
Condition
Condition
supraventricular tachycardia (atrial fibrillation, atrial tachycardia etc.)
Classification by specialty
| Cardiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To elucidate the key prognosis factor of rhythm control treatment (electric defibrillation,electric cardioversion, catheter ablation)
Basic objectives2
Others
Basic objectives -Others
To elucidate the key proteins about arrhythmiaoccurence
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
To elucidate the key prognosis factor of rhythm control treatment (electric defibrillation,electric cardioversion, catheter ablation)
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with supraventricular tachycardia (atrial fibrillation, atrial tachycardia etc.).
Patients not younger than 20 years old (at the time of informed consent)
Genders do not matter.
Key exclusion criteria
Patients who were judged to be inappropriate for this study.
Target sample size
1000
Research contact person
Name of lead principal investigator
| 1st name | Naohiko |
| Middle name | |
| Last name | Takahashi |
Organization
Faculty of Medicine, Oita University
Division name
Department of Cardiology and Clinical Examination
Zip code
879-5593
Address
1-1, Idaigaoka, Hasamamachi, Yufu, Oita
TEL
097-586-5974
takanao@oita-u.ac.jp
Public contact
Name of contact person
| 1st name | Ichitaro |
| Middle name | |
| Last name | Abe |
Organization
Faculty of Medicine, Oita University
Division name
Department of Cardiology and Clinical Examination
Zip code
879-5593
Address
1-1, Idaigaoka, Hasamamachi, Yufu, Oita
TEL
097-586-5974
Homepage URL
i-taro@oita-u.ac.jp
Sponsor or person
Institute
Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University
Institute
Department
Personal name
Funding Source
Organization
Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Oita University IRB
Address
1-1, Idaigaoka, Hasamamachi, Yufu, Oita
Tel
097-549-4411
syomu@oita-u.ac.jp
Secondary IDs
Secondary IDs
YES
Study ID_1
1283
Org. issuing International ID_1
the Ethics Committee of Oita University Hospital
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
大分大学医学部附属病院
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 10 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2017 | Year | 09 | Month | 15 | Day |
Date of IRB
| 2017 | Year | 09 | Month | 20 | Day |
Anticipated trial start date
| 2017 | Year | 09 | Month | 20 | Day |
Last follow-up date
| 2041 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Not particular
Management information
Registered date
| 2017 | Year | 10 | Month | 20 | Day |
Last modified on
| 2021 | Year | 10 | Month | 26 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033857
